ZyVersa Therapeutics’ CEO, Stephen C. Glover, Featured on Benzinga All Access View ZyVersa Therapeutics' Benzinga All Access Interview To Learn About Key Development Milestones in 2024.

Reliance Global Group to Participate in the Benzinga All Access Event on July 22nd LAKEWOOD, NJ, July 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Reliance Global Group, Inc. (Nasdaq: RELI; RELIW) (“Reliance”, “we” or the “Company”), which combines artificial intelligence (AI)...

Mullen Automotive CEO to Be Featured on Benzinga’s ‘All Access’ Series BREA, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Mullen Automotive, Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an emerging electric vehicle (“EV”) manufacturer, announces...

Blue Star Foods to Participate on Benzinga All Access Friday, April 22 at 10:00am ET Miami, FL, April 21, 2022 (GLOBE NEWSWIRE) -- Blue Star Foods Corp., (“Blue Star,” the “Company,” “we,” “our” or “us”) (NASDAQ: BSFC), an integrated Environmental,...